Host innate immune responses to viral RNA

  • Funded by Swiss National Science Foundation (SNSF)
  • Total publications:24 publications

Grant number: 173085

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2017
    2021
  • Known Financial Commitments (USD)

    $1,108,800
  • Funder

    Swiss National Science Foundation (SNSF)
  • Principal Investigator

    Volker Thiel
  • Research Location

    Switzerland
  • Lead Research Institution

    Institut für Virologie und Immunologie Depart. Infektionskrankheiten und Pathologie Universität Bern
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

"Host innate immune responses to viral RNA"Background: Coronaviruses (CoVs) are RNA viruses that have long been known to cause severe disease in livestock and companion animals. In humans, severe and fatal respiratory diseases have been observed through the emergence of zoonotic CoVs, such as SARS-CoV and MERS-CoV. CoVs are well known to efficiently evade early innate immune responses and enzymatic functions within - and virus-host interactions at - the CoV replication/transcription complex (RTC) are key to efficiently evade early innate immune responses. Working hypothesis and aims: We hypothesize that induction of early innate immune responses to CoV heavily rely on the ability of host cell innate immune sensors to access and recognize viral RNA and that CoVs have evolved efficacious mechanisms to prevent early detection of viral RNA. We further hypothesize that these early virus-host interactions predominantly take place at the CoV RTC. In order to mechanistically understand these innate immune evasion strategies, we will "illuminate" the cellular environment of the CoV RTC to identify host cell factors that are required for CoV replication, and host cell factors that are targeting the CoV RTC to restrict CoV replication. The reverse genetic systems for the mouse hepatitis virus (MHV) and human coronavirus 229E (HCoV-229E) and well characterized recombinant mutant viruses will be used in combination with murine and human models of infection to dissect key steps and key molecules involved in early innate immune responses on the molecular level. We will furthermore employ state-of-the-art technologies involving biotin ligase-mediated proximity labeling and proteomics, CRISPR/Cas9-based functional screens, and transcriptomics in combination with ribosomal profiling to obtain a detailed mechanistic view on (i) key interactions involved in early innate immune responses, (ii) the kinetics of these interactions and (iii) the kinetics of the global host cell response under well-defined conditions. These studies will provide spatial and temporal view of basic principles of viral RNA recognition and antiviral innate immune mechanisms in different primary cell types following virus infection. Expected significance: Our proposed studies will reveal basic principles of viral RNA sensing and antiviral innate immune effector mechanisms that are highly relevant also beyond CoV infections. We expect to identify key molecules, mechanisms and pathways that promote or restrict viral replication at the site of viral RNA synthesis. This information will further our understanding on fundamental aspects of viral RNA synthesis and innate immune responses to RNA virus infection, and will facilitate the development of novel strategies to interfere with viral RNA replication during the early phase of infections. Keywords viral RNA synthesis; innate immunity; type I interferon; RNA decay; reverse genetics; viral RNA sensing; RNA virus; Coronavirus; virus replication complex Hauptdisziplin Molekularbiologie

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Conserved requirement of autophagy-related effectors during coronavirus replication.

A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.

Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation.

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta).

Replication and single-cycle delivery of SARS-CoV-2 replicons.

Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.

A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets

Convergent use of phosphatidic acid for Hepatitis C virus and SARS-CoV-2 replication organelle formation

Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.